• Tech Launch Perspective
    July 22, 2026

    Life sciences enterprises are moving beyond isolated generative AI pilots toward governed, multi-agent workflows that support clinical, commercial, and real-world activities. This shift is increasing demand for platforms that combine regulatory-grade data governance, enterprise interoperability, scalable…
  • Tech Launch Perspective
    Feb. 26, 2026

    Life sciences enterprises are under pressure to accelerate research, improve evidence generation, and operationalize AI across clinical and commercial functions. Fragmented data estates, evolving regulatory requirements, and the growing importance of real-world and genomic data are…
  • Voice of the Partner
    Dec. 15, 2025

    Global technology ecosystems are rapidly transforming as enterprises increasingly rely on channel partners to deliver integrated, outcome-driven solutions. As technology stacks expand and customer expectations rise, technology providers are reshaping their partner engagement models to drive…
  • Viewpoint
    May 26, 2023

    Life sciences enterprises are evolving their commercial technology landscape to suit changing customer preferences and are shifting from a completely physical, representative-based sales model to a more stable hybrid commercial model. To unlock maximum value from…
  • Thematic Report
    Sep. 15, 2022

    Life sciences enterprises are actively transforming their commercial operations to meet business demands. Industry-agnostic technologies in the commercial space lack the real-time or data integration capabilities specific to the life sciences domain (that analytics & AI…
  • Thematic Report
    Nov. 03, 2020

    Digital technologies continue to dramatically reshape industries, and it is evident that the future of global services delivery is digital. Enterprises continue to invest extensively in Data and Analytics (D&A) services delivery to overhaul their existing…